Internal Medicine
3 questionsThalassemia gives protection against ?
Response to iron therapy in iron deficiency anemia is denoted by?
Which of the following is not a typical feature of haemolytic uremic syndrome?
NEET-PG 2013 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 371: Thalassemia gives protection against ?
- A. Protection against filaria
- B. Protection against kala-azar
- C. Protection against leptospirosis
- D. Protection against malaria (Correct Answer)
Explanation: Protection against malaria - Individuals with thalassemia, particularly thalassemia trait, have some degree of protection against severe forms of malaria, specifically Plasmodium falciparum [1]. - The altered red blood cell structure and reduced hemoglobin content in thalassemia make the red blood cells less hospitable for the parasites, hindering their replication and survival [1]. Protection against filaria - Filaria is caused by parasitic worms (nematodes) transmitted by mosquitoes, leading to lymphatic filariasis (elephantiasis) or onchocerciasis (river blindness). - Thalassemia's primary impact is on red blood cell health and oxygen transport, offering no known protective effect against nematode infections or their associated pathology. Protection against kala-azar - Kala-azar (visceral leishmaniasis) is caused by Leishmania parasites transmitted by sandflies, primarily affecting the reticuloendothelial system (spleen, liver, bone marrow). - There is no established scientific evidence indicating that thalassemia provides protection against Leishmania infections or their clinical manifestations. Protection against leptospirosis - Leptospirosis is a bacterial infection caused by Leptospira bacteria, typically acquired through contact with contaminated water or animal urine. - Thalassemia is a genetic blood disorder; its physiological effects are unrelated to the mechanisms of infection or immunity against bacterial pathogens like Leptospira.
Question 372: Response to iron therapy in iron deficiency anemia is denoted by?
- A. Increase in hemoglobin
- B. Reticulocytosis (Correct Answer)
- C. Restoration of enzymes
- D. Increase in iron binding capacity
Explanation: Reticulocytosis - Reticulocytosis is one of the earliest signs of a positive response to iron therapy in iron deficiency anemia, occurring within 5-10 days. - It signifies that the bone marrow is effectively producing new red blood cells after iron supplementation. Restoration of enzymes - While iron is a crucial component of many enzymes (e.g., catalase, cytochrome oxidase), its restoration takes time and is not the primary immediate indicator of therapeutic response. - Clinical improvement and other hematological parameters precede the full restoration of enzyme function. Increase in hemoglobin - An increase in hemoglobin is a definitive sign of successful treatment, but it occurs later than reticulocytosis, typically visible after several weeks to months of therapy. - Hemoglobin levels rise as the new, iron-sufficient red blood cells fully mature and replace the older, iron-deficient ones. Increase in iron binding capacity - In iron deficiency anemia, total iron-binding capacity (TIBC) is typically increased due to more transferrin being available to bind iron [1]. - Successful iron therapy would lead to a decrease in TIBC as transferrin sites become saturated with iron, not an increase.
Question 373: Which of the following is not a typical feature of haemolytic uremic syndrome?
- A. Splenomegaly (Correct Answer)
- B. Anemia
- C. Renal microthrombi
- D. Hyperkalemia
Explanation: ***Neuro psychiatric disturbances*** - Neuropsychiatric disturbances are not a direct feature of hemolytic uremic syndrome (HUS), which primarily affects renal and hematological systems. - HUS is characterized by a triad of **hemolytic anemia**, **thrombocytopenia**, and **acute renal failure**, without specific neuropsychiatric manifestations [2]. *Anaemia* - **Hemolytic anemia** is a key feature of HUS due to red blood cell destruction [1], [2]. - Patients often exhibit signs of **fatigue and pallor**, distinguishing it from other renal syndromes [3]. *Renal microthrombi* - HUS is characterized by the formation of **microthrombi in renal vasculature**, leading to acute kidney injury [1]. - The presence of these microthrombi is fundamental to the pathology of HUS [1]. *Hyperkalemia* - Renal failure in HUS can lead to **hyperkalemia** due to decreased potassium excretion. - It is a common complication associated with the acute renal failure seen in HUS.
Microbiology
1 questionsPersons with heterozygous sickle cell trait are protected from infection by:
NEET-PG 2013 - Microbiology NEET-PG Practice Questions and MCQs
Question 371: Persons with heterozygous sickle cell trait are protected from infection by:
- A. Pneumococcus
- B. P. falciparum (Correct Answer)
- C. P. vivax
- D. Salmonella
Explanation: ***P. falciparum*** - Individuals with heterozygous sickle cell trait have a **protective effect** against severe malaria caused by *P. falciparum* due to altered red blood cell morphology [1][2]. - The sickle hemoglobin (HbAS) provides a **selective advantage**, reducing the severity of malaria infections and the parasitic load [2][3]. *P. vivax* - Sickle cell trait does not confer significant protection against *P. vivax*, which primarily infects non-sickled red blood cells [2]. - The infection still occurs in individuals with the trait because it specifically affects the reticulocyte count, which is less impacted by sickling. *Salmonella* - While sickle cell disease is linked with increased susceptibility to **Salmonella infections**, the sickle cell trait itself does not provide protection against it [2]. - The trait does not influence immunity or susceptibility to bacterial pathogens like *Salmonella*. *Pneumococcus* - Individuals with sickle cell trait still have a normal risk of **invasive pneumococcal disease**, similar to those without the trait [2]. - Protection against *Pneumococcus* primarily relates to vaccination status and not to hemoglobinopathies. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 398-400. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 50-51.
Pathology
6 questionsWhich of the following statements is false regarding hereditary spherocytosis?
Which of the following statements about sickle cell anemia is false?
Donath-Landsteiner antibody is seen in?
According to WHO/ISN classification, which class of lupus nephritis shows a membranous pattern in SLE?
What is the primary mechanism involved in the pathogenesis of acute proliferative glomerulonephritis?
Which of the following is a primary pleural tumor?
NEET-PG 2013 - Pathology NEET-PG Practice Questions and MCQs
Question 371: Which of the following statements is false regarding hereditary spherocytosis?
- A. Defect in ankyrin
- B. Reticulocytosis
- C. Decreased MCHC (Correct Answer)
- D. Normal to increased MCV
Explanation: ***Decreased MCHC*** - Hereditary spherocytosis typically presents with an **increased MCHC** due to the spherocytes being more concentrated. - MCHC is a measure of the hemoglobin concentration in red blood cells, and in spherocytosis, this value is often elevated rather than decreased. *Defect in ankyrin* - This is a true statement; hereditary spherocytosis is associated with a defect in **ankyrin**, a protein that helps maintain the cell's membrane structure [2]. - Mutations in ankyrin lead to instability of the red blood cell membrane, resulting in spherocyte formation [2]. *Decreased MCV* - In hereditary spherocytosis, MCV is often **normal or slightly increased**, as it reflects the volume of red blood cells, which can be misinterpreted due to the presence of spherocytes. - Spherocytes are smaller cells, which can mistakenly suggest a falsely decreased MCV if not properly interpreted [1]. *Reticulocytosis* - This condition typically presents with **reticulocytosis** as a response to hemolysis, indicating the bone marrow is producing more red blood cells to compensate [1]. - The presence of reticulocytosis is a common finding in hereditary spherocytosis due to increased destruction of spherocytes. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 597-598. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 640-641.
Question 372: Which of the following statements about sickle cell anemia is false?
- A. Sickle cells are present in sickle cell anemia.
- B. Target cells are commonly seen in sickle cell anemia.
- C. Ringed sideroblasts are associated with sickle cell anemia. (Correct Answer)
- D. Howell Jolly bodies can be found in sickle cell anemia.
Explanation: ***Ringed sideroblast*** - **Ringed sideroblasts** are not typically associated with sickle cell anemia; they are indicative of disorders like **sideroblastic anemia**. - In sickle cell anemia, the primary findings include **hemolysis** and ineffective erythropoiesis, not ringed sideroblasts [3]. *Howell jolly bodies* - These bodies are remnants of nuclear material and can be found in individuals with **spleen dysfunction**, which can occur in sickle cell anemia [1]. - They are actually a common finding due to **hyposplenism** or **asplenia** in patients with sickle cell disease [2]. *Sickle cells* - The presence of **sickle-shaped red blood cells** is a hallmark of sickle cell anemia, caused by the mutation in the **beta-globin chain** [3]. - These sickle cells are responsible for the characteristic complications of the disease, such as **vaso-occlusive crises** [1][3]. *Target cells* - Target cells, or **codocytes**, are often seen in disorders like **thalassemia** and liver disease, and can also be present in sickle cell anemia. - They are formed due to an increase in the **surface area to volume ratio** of red blood cells, often secondary to **membrane abnormalities** seen in sickle cell changes [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 644-646. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 570-571. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599.
Question 373: Donath-Landsteiner antibody is seen in?
- A. PNH
- B. Waldenstrom's macroglobulinemia
- C. Malaria
- D. Paroxysmal cold hemoglobinuria (Correct Answer)
Explanation: ***Paroxysmal cold hemoglobinuria*** - **Donath-Landsteiner antibody** is a **biphasic IgG autoantibody** that binds to red blood cells in the cold and causes **hemolysis** upon warming, characteristic of paroxysmal cold hemoglobinuria. - This antibody has **anti-P specificity**, meaning it targets the P antigen on red blood cells, leading to complement activation and cell lysis. *PNH* - **Paroxysmal nocturnal hemoglobinuria** (PNH) is characterized by a deficiency in **GPI-anchored proteins** on red blood cells, notably **CD55** and **CD59**, making them susceptible to complement-mediated lysis. - It is not associated with the Donath-Landsteiner antibody; rather, it is identified by **flow cytometry** showing absence of CD55/CD59. *Waldenstrom's macroglobulinemia* - This is a **B-cell lymphoma** characterized by the overproduction of **monoclonal IgM antibodies**, leading to hyperviscosity syndrome and other symptoms. - It does not involve Donath-Landsteiner antibodies or cold-induced hemolysis in the same manner as paroxysmal cold hemoglobinuria. *Malaria* - **Malaria** is caused by **Plasmodium parasites** that infect and destroy red blood cells, leading to hemolytic anemia and fever. - While it causes **hemolysis**, it is not mediated by the Donath-Landsteiner antibody; the destruction is primarily due to parasitic replication and immune responses against infected cells.
Question 374: According to WHO/ISN classification, which class of lupus nephritis shows a membranous pattern in SLE?
- A. Diffuse proliferative pattern
- B. Membranous pattern (Correct Answer)
- C. Mesangial pattern involvement
- D. Focal proliferative pattern
Explanation: ***Membranous pattern*** - This corresponds to **Class V lupus nephritis** in the WHO/ISN classification, characterized by widespread immune complex deposition along the **glomerular basement membrane (GBM)**. - The subepithelial immune deposits lead to GBM thickening, creating the characteristic membranous pattern on light microscopy. - This pattern resembles idiopathic membranous nephropathy but occurs in the context of SLE. *Mesangial pattern involvement* - This refers to **Class I (minimal mesangial LN)** or **Class II (mesangial proliferative LN)**, where immune deposits are primarily confined to the mesangium. - There is minimal or no involvement of the glomerular capillary walls, distinguishing it from the membranous pattern. *Diffuse proliferative pattern* - This is **Class IV lupus nephritis**, the most severe form characterized by widespread **endocapillary and/or extracapillary proliferation** involving ≥50% of glomeruli. - The primary feature is cellular proliferation (mesangial, endocapillary, epithelial crescents), not the subepithelial immune deposits typical of membranous pattern. *Focal proliferative pattern* - This corresponds to **Class III lupus nephritis**, involving **endocapillary or extracapillary proliferation** in <50% of glomeruli. - Distinguished by focal (not diffuse) involvement and active proliferation rather than the membranous pattern seen in Class V.
Question 375: What is the primary mechanism involved in the pathogenesis of acute proliferative glomerulonephritis?
- A. Immune complex mediated (Correct Answer)
- B. T-cell mediated cytotoxicity
- C. Direct antibody-mediated injury
- D. Type IV hypersensitivity reaction
Explanation: ***Immune complex mediated*** - The pathogenesis of **acute proliferative glomerulonephritis** is primarily caused by **immune complexes** that deposit in the glomeruli, leading to inflammation [1]. - This is typically associated with **post-streptococcal infections**, where the body's immune response generates complexes that affect kidney function [1]. *Cytotoxic T-cell mediated* - This mechanism involves T-cells directly damaging cells, which is not the primary cause of **acute proliferative glomerulonephritis**. - It is more relevant in conditions like **viral infections** or **transplant rejection**, rather than immune complex diseases. *Antibody mediated* - While antibodies play a role in various diseases, acute proliferative glomerulonephritis is primarily mediated by **immune complexes**, not just antibodies alone [1]. - This oes not account for the presence of **complexes formed from antigens**, which is crucial in the pathogenesis [1]. *Cell-mediated (Type IV)* - Type IV hypersensitivity involves delayed-type hypersensitivity, typically seen in **tuberculosis** or **contact dermatitis**, not in acute glomerulonephritis. - The inflammation in this case is due to **immune complexes**, rather than a purely cell-mediated response [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 910-916.
Question 376: Which of the following is a primary pleural tumor?
- A. Mesothelioma (Correct Answer)
- B. Myxoma
- C. Lipoma
- D. None of the options
Explanation: ***Mesothelioma*** - Mesothelioma is a **primary malignant tumor** of the pleura [1], commonly associated with **asbestos exposure** [2]. - It typically presents with symptoms like **pleuritic chest pain**, dyspnea, and pleural effusion. *Myxoma* - Myxoma is a **benign tumor** primarily found in the **heart**, particularly in the left atrium, not in the pleura. - It does not arise from pleural tissue and lacks the **malignant characteristics** of mesothelioma. *All* - This option suggests that multiple tumors can be primary pleural tumors, which is incorrect as only mesothelioma is recognized as such. - Other tumors like myxoma and lipoma do not originate in the pleura and thus cannot be classified as primary pleural tumors. *Lipoma* - Lipoma is a **benign tumor** made up of adipose tissue [3] and is typically found in *subcutaneous tissue*, not the pleural cavity. - It does not have the malignant potential or association with pleural disease that characterizes mesothelioma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 728-729. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 339-340. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1222.